EMN vs VYGR · P/E 21, rev $9.38B vs rev $5.8M
Eastman Chemical Company (EMN) versus Voyager Therapeutics Inc (VYGR) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported VYGR revenue for 2026-06-30 was $5.8M. Net income was -$52.4M. VYGR currently screens at market cap $225.4M.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. VYGR currently screens at market cap $225.4M.
Not investment advice. Open the EMN and VYGR stock pages for the full models.
Not investment advice.